Pilot Trial of an Emotion Regulation and Executive Functioning Intervention for Self-Injurious Thoughts and Behaviors (SITBs) in Children
Proof-of-Concept Trial of an Emotion Regulation and Executive Functioning Intervention for SITBs in Children
2 other identifiers
interventional
52
1 country
1
Brief Summary
The goal of this study is to develop and test an outpatient intervention for preadolescents (ages 7-12) with self-injurious thoughts and behaviors (SITBs). The main questions it aims to answer are:
- 1.Are the recruitment targets and study design feasible?
- 2.Is the new intervention feasible, acceptable, and appropriate?
- 3.Does the new intervention lead to more improvements in SITBs, mental health symptoms, and treatment targets relative to treatment as usual (TAU)?
- 4.Complete an initial baseline assessment to determine eligibility and assess SITBs, mental health symptoms, executive functioning, and emotion regulation
- 5.Participate in an intervention lasting 6-12 weeks, including weekly or biweekly sessions
- 6.Complete additional assessments at post-treatment and 3-month follow-up
- 7.Participate in an interview sharing their perceptions of the intervention
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2025
CompletedFirst Posted
Study publicly available on registry
December 15, 2025
CompletedStudy Start
First participant enrolled
December 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2028
Study Completion
Last participant's last visit for all outcomes
May 1, 2028
July 29, 2026
July 1, 2026
1.4 years
December 1, 2025
July 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of recruitment
% recruitment targets met (benchmark = 52 preadolescents enrolled within 13 months)
Calculated at enrollment
Secondary Outcomes (9)
Suicidal Ideation Intensity
From enrollment to 3-month follow-up at 20 weeks
Feasibility of Retention
From enrollment to the end of treatment at 8 weeks
Perceived Appropriateness of Intervention
From enrollment to the end of treatment at 8 weeks
Perceived Feasibility of Intervention
From enrollment to the end of treatment at 8 weeks
Perceived acceptability of intervention
From enrollment to the end of treatment at 8 weeks
- +4 more secondary outcomes
Other Outcomes (8)
Anxiety Symptoms
From enrollment to 3-month follow-up at 20 weeks
Depression Symptoms
From enrollment to 3-month follow-up at 20 weeks
Disruptive Behavior Symptoms
From enrollment to 3-month follow-up at 20 weeks
- +5 more other outcomes
Study Arms (2)
Preadolescent SITB Intervention
EXPERIMENTALExperimental intervention for preadolescent SITBs targeting executive functioning, emotion regulation, and other SITB risk factors
Treatment as Usual (TAU)
ACTIVE COMPARATORTreatment as Usual provided by outpatient mental health therapist
Interventions
Typical interventions Outpatient therapist would provide to a preadolescent with SITBs, based on their clinical judgement
Experimental intervention developed with end-users and experts to target emotion regulation, executive functioning, and other risk factors for SITBs in preadolescents
Eligibility Criteria
You may qualify if:
- between the ages of 7-12
- at least one caregiver/legal guardian able to participate (more permitted)
- experienced at least one episode of SITBs within the last month
- ability to attend weekly sessions in-person or via telehealth
- ability to attend baseline and post-treatment assessments in-person.
- estimated verbal IQ of 70 or greater
You may not qualify if:
- symptoms interfering with ability to participate in assessments/therapy (i.e., psychosis)
- estimated verbal IQ\<70 or previous diagnosis of intellectual development disorder
- requiring inpatient psychiatric stabilization or high-intensity intervention to prevent hospitalization
- active substance use
- ward of the state
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2025
First Posted
December 15, 2025
Study Start (Estimated)
December 1, 2026
Primary Completion (Estimated)
May 1, 2028
Study Completion (Estimated)
May 1, 2028
Last Updated
July 29, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
IPD from the randomized controlled trial will be shared with the NIMH National Data Archive.